Latest News about ANVS
Recent news which mentions ANVS
Publication Of Peer-Reviewed Study In Journal Of The Alzheimer's Association Could Mark A Significant Step For Longeveron
August 02, 2022
From Benzinga
Dear AMC Stock Fans, Mark Your Calendars for Aug. 4
July 07, 2022
From InvestorPlace
Annovis Bio (ANVS) Stock Soars 6% on Positive FDA Update
July 07, 2022
From InvestorPlace
From Benzinga
83 Biggest Movers From Yesterday
June 09, 2022
From Benzinga
50 Stocks Moving In Wednesday's Mid-Day Session
June 08, 2022
From Benzinga
From Benzinga
From Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
December 27, 2021
From Benzinga
Annovis Bio on Its Positive Results in Alzheimer's and Parkinson's Clinical Trials
December 27, 2021
From Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
December 03, 2021
From Benzinga
The Daily Biotech Pulse: J&J To Spin-off Consumer Health Business, AstraZeneca Earnings, Embattled Emergent To Buy Back Shares
November 12, 2021
From Benzinga
The Daily Biotech Pulse: Double Dose Of Positive Tidings For Merck, Alkermes Slips On Partial Termination Of J&J Licensing Deal, Amgen Migraine Drug Data
November 09, 2021
From Benzinga
The Week Ahead In Biotech (Nov. 7-Nov. 13): Earnings Taper Off, Multiple Conference Presentations, IPOs And More
November 08, 2021
From Benzinga
92 Biggest Movers From Friday
November 08, 2021
From Benzinga
44 Biggest Movers From Yesterday
October 15, 2021
From Benzinga
3 Stocks Insiders Are Buying
October 14, 2021
From Benzinga
EXCLUSIVE: Annovis Bio's Parkinson's Candidate Improves Speed, Motor Function Vs Placebo
October 05, 2021
Tickers
ANVS
From Benzinga
Here's How You Handle a Volatile Stock Like Cassava Sciences
September 02, 2021
From Motley Fool
Insiders Like Cassava Sciences, Which Might Be Good News
August 30, 2021
From InvestorPlace
From Benzinga
Better Biotech Stock: Cassava Sciences vs. Annovis Bio
August 26, 2021
From Motley Fool
Tread Carefully Before Pulling the Trigger on Cassava Sciences
August 20, 2021
From InvestorPlace
From Motley Fool
Why Is Biogen Pursuing a New Direction in Alzheimer's Research?
August 13, 2021
From Motley Fool
From InvestorPlace
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
